CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 828 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 830 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 828 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Grant or award Director acquired 12,647 shares (grant or award)
- 4 Open-market buy Director bought 5,385,208 shares at $5.00 ($26,926,040)
- 4 Grant or award Chief Accounting Officer acquired 6,691 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 2,277 shares (to pay taxes)
- 4 Open-market buy Director bought 3,614,792 shares at $5.00 ($18,073,960)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 758 shares (to pay taxes)
Page 5 of 39 · 776 filings